Riassunto
La PET (Positron Emission Tomography) è una tecnica di imaging tomografico per la quale è stato coniato il termine di metabolic imaging, volto a sottolineare il suo peculiare razionale diagnostico, basato sull’identificazione e caratterizzazione di un tumore mediante l’impiego di specifici radiofarmaci idonei a evidenziare le differenze metaboliche esistenti tra questo e i tessuti sani. Con la PET è infatti possibile studiare vari aspetti del metabolismo e della biologia di un tumore, quali la sua perfusione ematica e il suo metabolismo glucidico e aminoacidico; inoltre è consentito valutare la sua attività proliferat iva e la presenza di fenomeni ipossici nel contesto della massa tumorale [1].
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Bibliografia
Vallabhajosula B (2007) (l8)F-labelled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistyry and mechanisms of tumor localization. Semin Nucl Med 37:400–419
Mittra E, Quon A (2009) Positron emission tomography/computed tomography: the curernt technology and applications. Radiol Clin North Am 47:147–160
Even-Sapir E, Keidar Z, Bar-Shalom R (2009) Hybrid imaging (SPECT/CT and PET/CT) improving the diagnostic accuracy of functional/metabolic and anatomic imaging. Semin Nucl Med 39:264–275
Poeppel TD, Krause BJ, Heusner TA et al (2009) PET/CT for the staging and follow-up of patients with malignancies. Eur J Radiol 70:382–392
Delbeke D, Scoder H, Martin WH, Wahl RL (2009) Hybrid Imaging (SPECT/CT and PET/CT): improving therapeutic decisions. Semin Nucl Med 39:308–340
Ishikita T, Oriuchi N, Higuchi T et al (2010) Additional value of integrated PET/CT over PET alone in the initial staging and follow-up fo head and neck malignancy. Ann Nucl Med 24:77–82
Wahl RL, Jacene H, Kasamon Y, Logde MA (2009) From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors. J Nucl Med 50:122S–50S
Geus-Oei, Oyen WJ (2008) Predictive and prognostic value of FDG-PET Cancer Imaging 28:70–80
Rosenbaum SJ, Lind T, Antoch G, Bockisch A (2006) False-positive FDG PET uptake: The role of PET/CT. Eur Radiol 16:1054–1065
Cook GJ (2007) Pitfalls in PET/CT interpretation. Clin Radiol 62:97–108
Roy FN, Beaulieu S, Boucher L et al (2009) Impact of intravenous insulin on 18F-FDG PET in diabetic cancer patients. J Nucl Med 50:178–183
Al-Ibraheem Al, Buck A, Krause BJ et al (2009) Clinical applications of FDG PET and PET/CT in Head and Neck Cancer J Oncol 208 725
Garcia C, Flamen P (2008) Role of positron emission tomography in the management of head and neck cancer in the molecular therapy era Curr Opin Oncol 20:275–279
Sher DJ, Tishler RB, Annino D, Punglia RS (2009) Costeffectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer. Ann Oncol 21:1072–1077
Fencl P, Belohlaveck O, Skopalova M et al (2007) Prognostic and diagnostic accuracy of [18F]FDG-PET/CT in 190 patients with carcinoma of unknown origin. Eur J Nucl Med Mol Imaging 34:1783–1792
Hustinx R, Lucignani G (2010) PET/TC in head and neck cancer: an update. Eur J Nucl Med Mol Imaging 37:645–651
Baek CH, Chung MK, Jeong HS et al (2009) The clinical usefulness of 18F-FDG PET/TC for the evalutation of lymph node metastasis in periorbital malignancies. Korean J Radiol 10:1–7
Yoon DY, Hwang HS, Chang SK et al (2009) CT, MR, US, 18F-FDG PET/CT and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Eur Radiol 19:634–642
Pohar S, Brown R,Newman N, Koniarczyk M et al (2007) What does PET imaging add to conventional staging of head and neck cancer patients? Int J Radiat Oncol Biol Phys 68:383–387
Roh JL, Yeo NK, Kim JS et al (2007) Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and emission head and neck squamous cell carcinoma Oral Oncol 43:887–893
Kim MR, Roh JL, Kim S et al (2007) Utility of 18F-fluorodeoxyglucose positron emission tomography in the preoperative staging of squamous cell carcinoma of the oropharynx. Eur J Surg Oncol 33:633–638
Jeong HS, Baek C, Son YI et al (2007) Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical node evaluation in patients with head and neck squamous cell carcinoma. Head Neck 29:203–210
Gordin A, Daitzchman I, Doweck I et al (2006) Fluorodeoxyglucose-positron emission tomo graphy/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management Laryngoscope 116:273–278
Hafidh MA, Lacy PD, Hughes JP et al (2006) Evaluation of the impact of addition of PET to CT and MR scanning in the staging of patients with head and neck carcinomas. Eur Arch Otorhinolaryngol 263:853–859
Ng SH, Yen TC, Liao CT et al (2005) 18F-FDG PET and CT/MRI on oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation. J Nucl Med 46:1136–1143
Ng SH, Chan SC, Yen TC et al (2009) Staging of untreated nasopharyngeal carcinoma with PET/CT:comparison with conventional imaging work-up. Eur J Nucl Mol Imaging 36:12–22
Krabbe CA, Pruim J, Van Der Laan BF et al (2009) FDG-PET and detection of distait metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT. Oral Oncol 45:234–240
Chua ML, Ong SC, Wee T et al (2009) Comparison of 4 modalities for distant metastasis staging in endemic nasopharyngeal carcinoma Head Neck 31:346–354
Liu FY, Lin CY, Chang JT et al (2007) 18F-FDG PET can replace conventional work-up in primary M staging of nonkeratinizing nasopharyngeal carcinoma. J Nucl Med 48:1614–1619
Chang JT, Chan SC, Yen TC et al (2005) Nasopharyngeal carcinoma staging by (18)F-Fluorodeoxyglucose positron emission tomography. Int J Radiat Oncolo Biol Phys 62:501–507
Schwartz DL, Rajendran J, Yueh B et al (2003) Staging of head and neck squamous cell cancer with extended-filed FDG-PET Arch of Otolaryngol Head Neck Surg 129:1173–1178
Schmid DT, Stoeckli SJ, Bandhauer f et al (2003) Impact of positron emission tomography in the initial staging and therapy in locoregional advanced squamous cell carcinoma of the oral cavity. Oral Oncol 39:547–551
Padovani D, Aimoni C, Zucchetta P et al (2009) 18-FDG PET in the diagnosis of laterocervical metastases from occult carcinoma. Eur Arch Otorhinolaryngol 266:267–271
Wartski M, Le Stanc E, Gontier E et al (2007) In search of an unknown primary tumour presenting with cervical metastases: performance for hybrid FDG-PET/TC. Nucl Med Commun 28:365–371
Paul Sa, Stoeckli SJ, Schulthess GK, Goerres GW (2007) FDG and PET/CT for detection of the primary tumour in patients with cervical non squamous cell carcinoma metastasis of an unknown primary. Eur Arch Otorhinolaryngol 264:189–195
Silva P, Hulse P, Sykes AJ et al (2007) Should FDG-PET scanning be routinely used for patients with an unknon head and neck squamous primary? J Laringol Otol 121:149–153
Fakhry N, Jacob J, Paris J et al (2006) Contribution of 18-F-FDG PET for detection of head and neck carcinomas with an unknown primary tumor. Ann Otolaryngol Chir Cervicofac 123:17–25
Wong WL, Saumders M (2003) The impact of FDG PET on the management of occult primary head and neck tumours. Clin Incol (R Coll Radiol) 15:461–466
Abgral R, Querellou S, Potard G et al (2009) Does 18F-FDG PET/CT improve the detection of post treatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? J Nucl Med 50:24–29
Wang YF, Liu RS, Chu PY et al (2009) Positron emission tomography in surveillance of head and neck squamous cell carcinoma after definitive chemoradiotherapy. Head Neck 31:442–451
Salaun PY, Abgral R, Querellou S et al (2007) Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients treated for head and neck squamous cell carcinoma with negative clinical follow-up? Head Neck 29:1115–1120
Alvarez Perez RM, Borrego Dorado I, Ruiz Franco-Baux JV, Vazquez Albertino RJ (2007) Evaluation of efficacy and clinical impact of positron emission tomography with 18F fluoro-deoxyglucose in patients with suspicion of recurrent head neck cancer or distant metastases. Revista Espanola de Medicina Nuclear 26:30–39
Cermik TF, Mavi A, Acikgoz G et al (2007) FDG-PET in detecting primary and recurrent malignant vsalivary gland tumors. Clin Nucl Med 32:286–291
Guido A, Fuccio L, Rombi B et al (2008) Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer. Int J Radiat Oncol Biol Phys 73:759–763
Breen SL, Publicover J, De Silva S et al (2007) Intraobserver and interobserver variability in GTV delineation on FDGPET-CT images of head and neck cancers. Int J Radiat Oncol Biol Phys 68:763–770
El-Bassiouni M, Ciernik F, Davis JB et al (2007) [18FDG] PET-CT based intensity-modulated radiotherapy treatment planning of head and neck cancer. Int J Radiat Oncol Biol Phys 69:286–293
Wang D, Schultz CJ, Jursinic PA et al (2006) Initial experience of FDG-PET/CT guided IMRT of head and neck carcinoma. Int J of Radiat Oncol Biol Phys 65:143–151
Riegel AC, Berson Am, Destian S et al (2006) Variability of gross tumor volume delineation in head and neck cancer using CT and PET CT fusion. Int J Radiat Oncol Biol Phys 65:726–732
Paulino AC, Koshy M, Howell R et al (2005) Comparison of CT and FDG-PET defined gross tumor volume in intensity modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 61:1385–1392
Heron D, Andrade R, Flickinger J et al (2004) Hybrid PET-CT simulation for radiation treatment planning in head-and neck cancer: a brief technical report. Int J Radiat Oncol Biol Phys 60:1419–1424
Ciernik IF, Dizendorf E, Baumert BG et al (2003) Radiation treatment planning with an integrated positron emission and computer tomography (PET/TC): a feasibility study. Int J Radiat Oncol Biol Phys 57:853–863
Rajendran JG, Scwartz DL, O’Sullivan J et al (2006) Tumor hypoxia imaging with [F-18] fluoromiso-nidazole positron emission tomography in head and neck cancer. Clin Cancer Res 12:5435–5441
Rischin D, Hicks RJ, Fisher R et al (2006) Prognostic significance of [18F]-misonidazole positron emission tomography-detected tumor hypoxia in patients with advanced head and neck cancer randomly assigned to chemoradiation with or without tirapazamine: a substudy of Trans-Tasman radiation Oncology group study 98.02. Clinc Oncol 24:2098–2104
Lee N, Mechalakos JG, Nehmeh S et al (2008) Fluorine-18-labeled fluoromisonidazole positron emission computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys 70:2–13
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Italia
About this chapter
Cite this chapter
Crippa, F., Alessi, A., Bombardieri, E. (2011). Diagnostica per immagini: PET e PET/TC. In: Tumori della testa e del collo. Springer, Milano. https://doi.org/10.1007/978-88-470-1806-8_10
Download citation
DOI: https://doi.org/10.1007/978-88-470-1806-8_10
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1805-1
Online ISBN: 978-88-470-1806-8
eBook Packages: MedicineMedicine (R0)